Bolt Biotherapeutics, Inc. (BOLT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.02M | -7.16M | -9.73M | -9.6M | -13.37M | -14.43M | -13.97M | -16.14M | -16.75M | -14.27M | -16.75M | -15.11M |
| Operating CF Margin % | -30857.69% | -286.24% | -448.69% | -531.98% | -1093.7% | - | -1224.01% | -1266.04% | -317.61% | -682.86% | -662.54% | -1054.57% |
| Operating CF Growth % | 39.97% | 50.41% | 30.32% | 40.55% | 20.21% | -1.16% | 16.62% | -6.82% | 28.41% | 20.54% | -24.52% | 27.3% |
| Net Income | -7.24M | -6.63M | -7.14M | -8.56M | -11.04M | -15.94M | -15.18M | -21.2M | -10.81M | -17.9M | -16.26M | -18.06M |
| Depreciation & Amortization | 203K | 255K | 290K | 347K | 399K | 426K | 440K | 457K | 458K | 467K | 462K | 458K |
| Stock-Based Compensation | 0 | 1.04M | 407K | 625K | 709K | 1.18M | 1.1M | 2.83M | 2.3M | 2.07M | 2.33M | 2.35M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.33M | 0 |
| Other Non-Cash Items | 1.14M | 490K | 506K | 454K | 118K | 1.09M | 250K | -3K | -260K | -436K | 744K | -381K |
| Working Capital Changes | -2.12M | -2.31M | -3.79M | -2.46M | -3.55M | -1.2M | -578K | 1.77M | -8.44M | 1.54M | -2.69M | 518K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 7.92M | 1.07M | 17.88M | 10.79M | 14.55M | 12.23M | 17.14M | 18M | 10.2M | 15.81M | 12.66M | 13.58M |
| Capital Expenditures | 0 | 0 | -72K | 0 | 0 | 0 | -41K | 0 | 0 | -6K | -165K | -32K |
| CapEx % of Revenue | 30857.69% | - | 3.32% | - | - | - | 3.59% | - | - | 0.29% | 6.53% | 2.23% |
| Acquisitions | 31K | 963K | 0 | 0 | 963K | 0 | 0 | 0 | 0 | 0 | -12.82M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -963K | 0 | 0 | 0 | 0 | 148K | 0 | 0 | 0 | 12.82M | 0 |
| Cash from Financing | 6K | 5K | 0 | 14K | 0 | 29K | 0 | 79K | 0 | 106K | 0 | 147K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 6K | 5K | 14K | 0 | 0 | 29K | 0 | 79K | 0 | 106K | 0 | 147K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -14K | 14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -94K | -6.08M | 8.15M | 1.21M | 1.19M | -2.17M | 3.17M | 1.94M | -6.55M | 1.65M | -4.09M | -1.39M |
| Free Cash Flow | 0 | -7.16M | -9.8M | -9.6M | -13.37M | -14.43M | -14.01M | -16.14M | -16.75M | -14.27M | -16.91M | -15.14M |
| FCF Margin % | - | -286.24% | -452.01% | -531.98% | -1093.7% | - | -1227.61% | -1266.04% | -317.61% | -683.15% | -669.07% | -1056.8% |
| FCF Growth % | 100% | 50.41% | 30.01% | 40.55% | 20.21% | -1.11% | 17.19% | -6.59% | 28.42% | 21.31% | -19.23% | 28.62% |
| FCF per Share | - | -3.83 | -5.11 | -5.00 | -0.35 | -0.38 | -0.37 | -0.42 | -0.44 | -0.38 | -0.45 | -0.40 |
| FCF Conversion (FCF/Net Income) | 1.11x | 1.08x | 1.36x | 1.12x | 1.21x | 0.91x | 0.92x | 0.76x | 1.55x | 0.80x | 1.03x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |